Splash (SBEV) Adds +11.06% to Recent Winning Streak 2026-10-20 - RTH Profile

SPLASH BEVERAGE GROUP, INC. SEC Filing (Aug 25, 2026) | SBEV EFFECT

Splash Beverage Group to Become Endovia Health Sciences; New NYSE American Ticker “EDVA” Effective Monday

Splash Beverage Group to Rebrand as Endovia Health Sciences

Splash Beverage Group Partners with Veteran Cannabinoid Drug-Development Team to Advance CannEpil® Through FDA Veterinary Pathway

Splash Beverage Group Announces Significant Balance Sheet Improvement and Board Approval of Reverse Stock Split as Company Continues Strategic Transformation

Splash Beverage announces reverse stock split, settlement with creditors (SBEV:NYSE)

Splash Beverage Group Announces Significant Balance Sheet

Splash Beverage Group Receives NYSE American Acceptance of Compliance Plan, Establishing Defined Path Toward Continued Listing and Strategic Transformation

SPLASH BEVERAGE GROUP ACQUIRES EXCLUSIVE GLOBAL RIGHTS TO CANNEPIL®, AN EPILEPSY THERAPY WITH ESTABLISHED EUROPEAN PATIENT ACCESS, FDA ENGAGEMENT AND U.S. DEVELOPMENT POTENTIAL

SBEV Stock Tumbles Over 35% In Pre-Market Today — A Look At Its Latest Deal With Argent BioPharma

Monday's session: gap up and gap down stocks

Splash Beverage Group Secures Exclusive Global License to CannEpil for Drug-Resistant Epilepsy in Europe and Worldwide

Splash Beverage Group Invests in Avicanna, a Leading Cannabinoid Biopharmaceutical Platform, Advancing Its Transformation Into Cannabinoid Healthcare